ProfileGDS5822 / ILMN_1222606
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 17% 59% 18% 0% 4% 2% 27% 6% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11217
GSM1276600PDAC Late Ablation Control 230.859
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 110.918
GSM1276603PDAC Late Ablation 20.50
GSM1276604PDAC Late Ablation 35.14
GSM1303940PDAC Late Ablation_anti-CTLA4 14.82
GSM1303941PDAC Late Ablation_anti-CTLA4 213.527
GSM1303942PDAC Late Ablation_anti-CTLA4 34.76